X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs SANOFI INDIA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD SANOFI INDIA ALEMBIC LTD/
SANOFI INDIA
 
P/E (TTM) x 75.7 30.0 252.5% View Chart
P/BV x 2.8 5.3 53.1% View Chart
Dividend Yield % 0.4 1.7 23.4%  

Financials

 ALEMBIC LTD   SANOFI INDIA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
SANOFI INDIA
Dec-16
ALEMBIC LTD/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs534,560 1.2%   
Low Rs294,400 0.7%   
Sales per share (Unadj.) Rs4.71,028.5 0.5%  
Earnings per share (Unadj.) Rs8.8129.0 6.8%  
Cash flow per share (Unadj.) Rs9.0186.0 4.8%  
Dividends per share (Unadj.) Rs0.1568.00 0.2%  
Dividend yield (eoy) %0.41.5 24.1%  
Book value per share (Unadj.) Rs27.7753.6 3.7%  
Shares outstanding (eoy) m267.0323.03 1,159.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.74.4 199.7%   
Avg P/E ratio x4.734.7 13.5%  
P/CF ratio (eoy) x4.624.1 18.9%  
Price / Book Value ratio x1.55.9 24.9%  
Dividend payout %1.752.7 3.2%   
Avg Mkt Cap Rs m10,962103,174 10.6%   
No. of employees `000NA3.6 0.0%   
Total wages/salary Rs m2383,592 6.6%   
Avg. sales/employee Rs ThNM6,537.7-  
Avg. wages/employee Rs ThNM991.4-  
Avg. net profit/employee Rs ThNM819.8-  
INCOME DATA
Net Sales Rs m1,26023,686 5.3%  
Other income Rs m264708 37.3%   
Total revenues Rs m1,52424,394 6.2%   
Gross profit Rs m835,281 1.6%  
Depreciation Rs m611,313 4.7%   
Interest Rs m015 2.0%   
Profit before tax Rs m2854,661 6.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m61,691 0.4%   
Profit after tax Rs m2,3432,970 78.9%  
Gross profit margin %6.622.3 29.5%  
Effective tax rate %2.136.3 5.9%   
Net profit margin %185.912.5 1,482.5%  
BALANCE SHEET DATA
Current assets Rs m1,68915,673 10.8%   
Current liabilities Rs m4866,678 7.3%   
Net working cap to sales %95.438.0 251.3%  
Current ratio x3.52.3 148.0%  
Inventory Days Days21776 285.5%  
Debtors Days Days8122 363.2%  
Net fixed assets Rs m1,6248,098 20.1%   
Share capital Rs m534230 231.9%   
"Free" reserves Rs m5,96017,088 34.9%   
Net worth Rs m7,40417,356 42.7%   
Long term debt Rs m1040-   
Total assets Rs m8,01025,400 31.5%  
Interest coverage x950.7311.7 305.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.20.9 16.9%   
Return on assets %29.311.8 248.9%  
Return on equity %31.617.1 184.9%  
Return on capital %31.326.9 116.1%  
Exports to sales %2.924.5 12.0%   
Imports to sales %28.928.0 103.1%   
Exports (fob) Rs m375,801 0.6%   
Imports (cif) Rs m3646,627 5.5%   
Fx inflow Rs m377,145 0.5%   
Fx outflow Rs m3656,846 5.3%   
Net fx Rs m-328299 -109.6%   
CASH FLOW
From Operations Rs m3463,226 10.7%  
From Investments Rs m-48-1,555 3.1%  
From Financial Activity Rs m-301-1,818 16.6%  
Net Cashflow Rs m-3-147 2.0%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 0.2 14.4 1.4%  
FIIs % 9.7 14.6 66.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 10.5 248.6%  
Shareholders   54,701 15,184 360.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   IPCA LABS  NOVARTIS  DR. DATSONS LABS  MERCK LTD  GSK PHARMA  

Compare ALEMBIC LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 22, 2017 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - NATCO PHARMA COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS